Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic R Curtiss

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
Journal of Managed Care Pharmacy : JMCP|May 4, 2010
It depends on what "mean" means: averaging versus event patterning in analyses of administrative claims dataKathleen A Fairman, Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|August 24, 2006
Forecasting cholesterol management--end of the statin gold rush?Brian K Crownover, Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|February 25, 2009
Call for letters regarding disclosure of potential conflicts of interest in the managed care literature -- too much, too little, or just about right?Kathleen A Fairman, Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|October 7, 2009
Call for comparative effectiveness research: lowering A1c with sitagliptin, saxagliptin, or cinnamonKathleen A Fairman, Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|January 5, 2010
Utilization management opportunities for palivizumab for prophylaxis of respiratory syncytial virus complications in infantsFrederic R Curtiss, Kathleen A Fairman
Journal of Managed Care Pharmacy : JMCP|September 9, 2008
Diabetes drug therapy--first do no harmFrederic R Curtiss, Kathleen A Fairman
Journal of Managed Care Pharmacy : JMCP|September 19, 2007
ADD or ADHD or what exactly?-GIGO part II and other lessons in research with administrative claimsFrederic R Curtiss, Kathleen A Fairman
Journal of Managed Care Pharmacy : JMCP|December 4, 2009
No TREATment with darbepoetin dosed to hemoglobin 13 grams per deciliter in type 2 diabetes with pre-dialysis chronic kidney disease--safety warnings for erythropoiesis-stimulating agentsFrederic R Curtiss, Kathleen A Fairman
Journal of Managed Care Pharmacy : JMCP|September 9, 2008
Rethinking the "whodunnit" approach to assessing the quality of health care research--a call to focus on the evidence in evidence-based practiceKathleen A Fairman, Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|July 20, 2010
Tough questions about the value of statin therapy for primary prevention: did JUPITER miss the moon?Frederic R Curtiss, Kathleen A Fairman
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
Journal of Managed Care Pharmacy : JMCP|May 4, 2010
It depends on what "mean" means: averaging versus event patterning in analyses of administrative claims dataKathleen A Fairman, Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|August 24, 2006
Forecasting cholesterol management--end of the statin gold rush?Brian K Crownover, Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|February 25, 2009
Call for letters regarding disclosure of potential conflicts of interest in the managed care literature -- too much, too little, or just about right?Kathleen A Fairman, Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|October 7, 2009
Call for comparative effectiveness research: lowering A1c with sitagliptin, saxagliptin, or cinnamonKathleen A Fairman, Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|January 5, 2010
Utilization management opportunities for palivizumab for prophylaxis of respiratory syncytial virus complications in infantsFrederic R Curtiss, Kathleen A Fairman
Journal of Managed Care Pharmacy : JMCP|September 9, 2008
Diabetes drug therapy--first do no harmFrederic R Curtiss, Kathleen A Fairman
Journal of Managed Care Pharmacy : JMCP|September 19, 2007
ADD or ADHD or what exactly?-GIGO part II and other lessons in research with administrative claimsFrederic R Curtiss, Kathleen A Fairman
Journal of Managed Care Pharmacy : JMCP|December 4, 2009
No TREATment with darbepoetin dosed to hemoglobin 13 grams per deciliter in type 2 diabetes with pre-dialysis chronic kidney disease--safety warnings for erythropoiesis-stimulating agentsFrederic R Curtiss, Kathleen A Fairman
Journal of Managed Care Pharmacy : JMCP|September 9, 2008
Rethinking the "whodunnit" approach to assessing the quality of health care research--a call to focus on the evidence in evidence-based practiceKathleen A Fairman, Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|July 20, 2010
Tough questions about the value of statin therapy for primary prevention: did JUPITER miss the moon?Frederic R Curtiss, Kathleen A Fairman
Pageof 14